Comparison of survival outcomes after adjustment for confounders. (A) MVAs of factors potentially impacting survival. (B) PSMW sensitivity analysis for patients treated with axi-cel and liso-cel, adjusting for factors that may have influenced product selection. CR, complete response; DLBCL, diffuse large B-cell lymphoma; HGBL, high-grade B-cell lymphoma; LD, lymphodepletion; NOS, not otherwise specified; PD, progressive disease; PR, partial response; SD, stable disease.